CNR Institutional Research Information System

IANNOTTI, FABIO ARTURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.652
NA - Nord America 1.107
EU - Europa 469
SA - Sud America 305
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 36
OC - Oceania 3
AN - Antartide 1
Totale 3.678
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.044
SG - Singapore 657
CN - Cina 421
BR - Brasile 226
IT - Italia 192
HK - Hong Kong 178
VN - Vietnam 119
FR - Francia 85
KR - Corea 82
BD - Bangladesh 61
NL - Olanda 55
FI - Finlandia 38
AR - Argentina 34
IN - India 32
JP - Giappone 32
CA - Canada 24
DE - Germania 24
GB - Regno Unito 23
MX - Messico 17
IL - Israele 12
CO - Colombia 11
ES - Italia 11
PK - Pakistan 11
ZA - Sudafrica 11
VE - Venezuela 10
EC - Ecuador 9
ID - Indonesia 8
MA - Marocco 7
UA - Ucraina 7
IQ - Iraq 6
KE - Kenya 6
PY - Paraguay 6
SA - Arabia Saudita 6
JM - Giamaica 5
BY - Bielorussia 4
DZ - Algeria 4
MY - Malesia 4
PL - Polonia 4
RU - Federazione Russa 4
TR - Turchia 4
AZ - Azerbaigian 3
BE - Belgio 3
CL - Cile 3
CR - Costa Rica 3
EG - Egitto 3
IE - Irlanda 3
NI - Nicaragua 3
PE - Perù 3
SE - Svezia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
UZ - Uzbekistan 3
GA - Gabon 2
GT - Guatemala 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
TH - Thailandia 2
AL - Albania 1
AQ - Antartide 1
AT - Austria 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.573
Salva come PNG Salva come JPEG
Città #
Singapore 367
Hefei 181
Hong Kong 173
San Jose 167
Santa Clara 151
Ashburn 107
Beijing 98
Seoul 79
Lauterbourg 69
Naples 54
Ho Chi Minh City 44
Dallas 40
Los Angeles 40
Hanoi 35
Council Bluffs 27
New York 21
São Paulo 20
Helsinki 19
Tokyo 19
Buffalo 15
Lappeenranta 14
Rio de Janeiro 14
Rome 14
Milan 11
Shenzhen 11
Brooklyn 10
Minamishinagawa 10
Phoenix 10
Orem 9
Afragola 8
Casandrino 8
Da Nang 8
Frankfurt am Main 8
Houston 8
Bengaluru 7
Brasília 7
Buenos Aires 7
Columbus 6
Guangzhou 6
Johannesburg 6
London 6
Munich 6
Nairobi 6
Poplar 6
Amsterdam 5
Campinas 5
Chennai 5
Chicago 5
Medellín 5
Mexico City 5
Montreal 5
New Orleans 5
Newark 5
San Francisco 5
Asunción 4
Atlanta 4
Bogotá 4
Caracas 4
Dhaka 4
Falkenstein 4
Figino 4
Florence 4
Haiphong 4
Jacksonville 4
Lahore 4
Marseille 4
Miami 4
Nanjing 4
Philadelphia 4
Queens 4
Toronto 4
Turku 4
Antwerp 3
Belo Horizonte 3
Biên Hòa 3
Boardman 3
Boston 3
Campo Grande 3
Caxias do Sul 3
Charlotte 3
Cleveland 3
Curitiba 3
Dublin 3
Goiânia 3
Guayaquil 3
Istanbul 3
Itajubá 3
Kingston 3
Las Vegas 3
Macaé 3
Mumbai 3
Padua 3
Porto Alegre 3
Providence 3
Quito 3
Québec 3
Rabat 3
Salvador 3
San José 3
Stockholm 3
Totale 2.138
Salva come PNG Salva come JPEG
Nome #
2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors 129
First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury 101
Orexin-A and endocannabinoids are involved in obesity-associated alteration of hippocampal neurogenesis, plasticity, and episodic memory in mice 96
N-Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth 88
Editorial: "Small molecules targeting transmembrane receptors and ion channels in drug discovery" 82
The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity 82
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity 82
Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI 78
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. 77
N-palmitoyl-d-glucosamine, a natural monosaccharide-based glycolipid, inhibits tlr4 and prevents lps-induced inflammation and neuropathic pain in mice 77
Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis 75
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus. 71
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy 68
In silico identification and experimental validation of (-)-muqubilin A, a marine norterpene peroxide, as PPARalpha/gamma-RXRalpha agonist and RARalpha positive allosteric modulator 68
The gut microbiome, endocannabinoids and metabolic disorders. 66
The (Poly)pharmacology of cannabidiol in neurological and neuropsychiatric disorders: Molecular mechanisms and targets 66
NAAA is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth 63
Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin 63
Alternanza Scuola Lavoro Liceo Scientifico Galilei-Mondragone (Ce), AS 2017/18 62
TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β-catenin signalling 62
Identification and characterization of cannabidiol as an ox1r antagonist by computational and in vitro functional validation 62
Identification of Cannabidiolic and Cannabigerolic Acids as MTDL AChE, BuChE, and BACE‐1 Inhibitors Against Alzheimer's Disease by In Silico, In Vitro, and In Vivo Studies 60
Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy 57
Protective Effects of N-Oleoylglycine in a Mouse Model of Mild Traumatic Brain Injury 55
Beneficial effects of akkermansia muciniphila are not associated with major changes in the circulating endocannabinoidome but linked to higher mono-palmitoyl-glycerol levels as new pparα agonists 54
Cannabinoids, Endocannabinoids, and Synthetic Cannabimimetic Molecules in Neuromuscular Disorders 52
Alternanza Scuola Lavoro Liceo Scientifico Colombo-Marigliano (Na), AS 2017/18 52
Neuroendocrine Transdifferentiation in Human Prostate Cancer Cells: An Integrated Approach 51
Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPARgamma Agonist via a Combined Computational and Functional Study 51
Maternal omega-3 intake differentially affects the endocannabinoid system in the progeny`s neocortex and hippocampus: Impact on synaptic markers 51
PPARα/γ-Targeting Amorfrutin Phytocannabinoids from Aerial Parts of Glycyrrhiza foetida 51
Identification and characterization of phytocannabinoids as novel dual PPARalpha/gamma agonists by a computational and in vitro experimental approach 50
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 48
Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome 48
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 48
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia 47
Activation of cannabinoid type 1 receptor (CB1) modulates oligodendroglial process branching complexity in rat hippocampal cultures stimulated by olfactory ensheathing glia-conditioned medium 47
Assessment of the effects of dietary vitamin d levels on olanzapine-induced metabolic side effects: Focus on the endocannabinoidome-gut microbiome axis 47
Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice 45
Activation of Kv7 Potassium Channels Inhibits Intracellular Ca2+ Increases Triggered By TRPV1-Mediated Pain-Inducing Stimuli in F11 Immortalized Sensory Neurons 43
The endocannabinoid system and ppars: Focus on their signalling crosstalk, action and transcriptional regulation 43
The endocannabinoidome in human placenta: Possible contribution to the pathogenesis of preeclampsia 43
Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets 42
Duchenne's muscular dystrophy involves a defective transsulfuration pathway activity 42
Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors 41
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels. 40
Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions 39
Phytocannabinoid treatment in a mouse model of West syndrome with spontaneous seizures 39
The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG. 38
Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor 38
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability 36
Early Low-Fat Diet Enriched With Linolenic Acid Reduces Liver Endocannabinoid Tone and Improves Late Glycemic Control After a High-Fat Diet Challenge in Mice 35
Peripubertal cannabidiol treatment rescued behavioral and neurochemical abnormalities in MAM model of schizophrenia. 34
Study of the expression profile and pharmacological role of CB1 receptor in Duchenne Muscular Dystrophy (DMD) muscles: a new opportunity to reinforce muscle repair and locomotor activity 34
Neuroprotective effects of N-oleoylglycine in a mouse model of mild traumatic brain injury 34
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in perinatal ?9-tetrahydrocannabinol occurs in schizophrenia: analyses in patients and in animal model of the disease. 32
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. 32
Efficacy of combined therapy with fish oil and phytocannabinoids in murine intestinal inflammation 29
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients 28
The endocannabinoid system in renal cells: regulation of Na+ transport by CB1 receptors through distinct cell signalling pathways 28
Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats 27
The endocannabinoid system controls skeletal muscle cell differentiation via CB1 receptor-dependent hydrolysis of PIP2 and ihibition of Kv7 potassium channels 25
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Delta9-tetrahydrocannabinol-exposed rats 25
Pharmacological actions and potential therapeutic use of cannabinoids in Duchenne's muscular dystrophy 25
Nociceptor plasticity: a closer look. 25
Role of the endocannabinoid system in the control of mouse myometrium contractility during the menstrual cycle 24
Analysis of the "endocannabinoidome" in peripheral tissues of obese Zucker rats 24
Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system 23
THE NON-PSYCHOTROPIC PLANT CANNABINOIDS, CANNABIDIOL (CBD) AND CANNABIDIVARIN (CBDV) ACTIVATE AND DESENSITIZE TRPV1 CHANNELS IN VITRO: POTENTIAL FOR THE TREATMENT OF NEURONAL HYPEREXCITABILITY 23
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 23
Experimental ischemia/reperfusion model impairs endocannabinoid signaling and Na+/K+ ATPase expression and activity in kidney proximal tubule cells 23
Early pharmacological modulation of the endogenous cannabinoid signaling counteracts the phenotype in a rodent developmental disruption model of schizophrenia at adulthood 22
Study of the expression profile and pharmacological role of the CB1 receptor in Duchenne Muscular Dystrophy (DMD) muscles: a new opportunity to reinforce muscle repair and locomotor activity 20
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders 19
Attività laboratoriale "RigenerAzioni per combattere le malattie muscolari degenerative: studio di terapie innovative per ripristinare la rigenerazione tissutale nelle distrofie muscolari" nell'ambito del Progetto "RigenerAzioni: Percorsi di rigenerazione per l'economia circolare, i beni culturali e la salute" - Festival scientifico "Futuro Remoto" XXXII - Città della Scienza, Napoli, 5-8 novembre 2018 18
THE ENDOCANNABINOID SYSTEM CONTROLS SKELETAL MUSCLE CELL DIFFERENTIATION VIA CB1 RECEPTOR-DEPENDENT HYDROLYSIS OF PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE (PIP2) AND INHIBITION OF KV7 POTASSIUM CHANNELS 16
Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity 14
Totale 3.678
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.932
article - articoli 11.427
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 133
Totale 24.492
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024107 0 0 0 0 0 0 0 0 0 5 13 89
2024/20251.138 14 6 98 52 138 25 21 96 67 68 293 260
2025/20262.064 122 232 171 278 364 79 274 77 112 147 118 90
2026/2027369 108 110 151 0 0 0 0 0 0 0 0 0
Totale 3.678